Recent Quotes

Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Earnings

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-05
REV		(EXPECTED)2021-08-05

Q1 2021		Est.		Actual		Surprise
EPS		0.210		0.240		0.0300
REV		95.200M		88.845M		-6.355M

Analyst Ratings

Date	Analyst Firm	Analyst Name	Action	Rating	Action Price	Prior Price	Target

Related Companies

Ticker	Company	Price	Change	Chg %		Mkt Cap
IRWD	Ironwood Pharmaceuticals	13.16	0.00	0%		2.1B

Ironwood Pharmaceuticals Frequently Asked Questions

How do I buy Ironwood Pharmaceuticals (IRWD) stock?

You can purchase shares of Ironwood Pharmaceuticals (NASDAQ: IRWD) through any online brokerage.

View our list of the best stock brokerages.

Who are Ironwood Pharmaceuticals's (IRWD) competitors?

Other companies in Ironwood Pharmaceuticals’s space includes: bluebird bio (NASDAQ:BLUE), Zentalis Pharmaceuticals (NASDAQ:ZNTL), Centessa Pharmaceuticals (NASDAQ:CNTA), Prothena Corp (NASDAQ:PRTA) and Inovio Pharmaceuticals (NASDAQ:INO).

What is the target price for Ironwood Pharmaceuticals (IRWD) stock?

The latest price target for Ironwood Pharmaceuticals (NASDAQ: IRWD) was reported by Morgan Stanley on July 16, 2021. The analyst firm set a price target for 12.00 expecting IRWD to fall to within 12 months (a possible -8.81% downside). 7 analyst firms have reported ratings in the last year.

Current Stock Price for Ironwood Pharmaceuticals (IRWD)?

The stock price for Ironwood Pharmaceuticals (NASDAQ: IRWD) is $13.16 last updated Thu Jul 29 2021 20:00:01 GMT+0000 (Coordinated Universal Time).

Does Ironwood Pharmaceuticals (IRWD) pay a dividend?

There are no upcoming dividends for Ironwood Pharmaceuticals.

When is Ironwood Pharmaceuticals (NASDAQ:IRWD) reporting earnings?

Ironwood Pharmaceuticals’s Q2 earnings are confirmed for after-market on August 5, 2021.

Is Ironwood Pharmaceuticals (IRWD) going to split?

There is no upcoming split for Ironwood Pharmaceuticals.

What sector and industry does Ironwood Pharmaceuticals (IRWD) operate in?

Ironwood Pharmaceuticals is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.